This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/531188-southkorea-investment-covid19-moon-vaccine/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| South Korea to be one of world’s largest vaccine manufacturers, says Moon, pledging $1.92 billion investment | South Korea to be one of world’s largest vaccine manufacturers, says Moon, pledging $1.92 billion investment |
| (25 days later) | |
| The South Korean president’s office has announced plans to elevate the country to be one of the world’s largest vaccine producers with an investment of 2.2 trillion won ($1.92 billion) over the next four years. | The South Korean president’s office has announced plans to elevate the country to be one of the world’s largest vaccine producers with an investment of 2.2 trillion won ($1.92 billion) over the next four years. |
| On Thursday, President Moon Jae-in disclosed his intention to develop South Korea’s vaccine production base, his office said. The project will receive 2.2 trillion won ($1.92 billion) in investment until 2025 and will see South Korea become one of the top five countries in the world by vaccine manufacturing capacity. | On Thursday, President Moon Jae-in disclosed his intention to develop South Korea’s vaccine production base, his office said. The project will receive 2.2 trillion won ($1.92 billion) in investment until 2025 and will see South Korea become one of the top five countries in the world by vaccine manufacturing capacity. |
| Moon’s remarks were made during a committee meeting, featuring both public and private sector representatives, which discussed ways to boost Covid-19 shot production amid global shortages. | Moon’s remarks were made during a committee meeting, featuring both public and private sector representatives, which discussed ways to boost Covid-19 shot production amid global shortages. |
| The president said Covid-19 vaccines will be one of three national strategic technologies, the others being the production of semiconductors and batteries. | The president said Covid-19 vaccines will be one of three national strategic technologies, the others being the production of semiconductors and batteries. |
| South Korea is by no means the first country to implement plans to nearshore vaccine production during the pandemic. Covid-19 has highlighted the need for security of supply when it comes to pharmaceuticals and life-saving vaccines, but also the ability of the industry to generate jobs. | South Korea is by no means the first country to implement plans to nearshore vaccine production during the pandemic. Covid-19 has highlighted the need for security of supply when it comes to pharmaceuticals and life-saving vaccines, but also the ability of the industry to generate jobs. |
| Facilities in the UK now manufacture AstraZeneca and Novavax jabs and will produce shots made by Valneva should the vaccine pass the required trial phase. Before the pandemic, Britain had almost no vaccine manufacturing capacity. | Facilities in the UK now manufacture AstraZeneca and Novavax jabs and will produce shots made by Valneva should the vaccine pass the required trial phase. Before the pandemic, Britain had almost no vaccine manufacturing capacity. |
| AstraZeneca and the Novavax shot are both produced in South Korea, but the national immunization rate is comparatively low. To date, only 7.4 million people have received two shots in the nation of 51 million people. | AstraZeneca and the Novavax shot are both produced in South Korea, but the national immunization rate is comparatively low. To date, only 7.4 million people have received two shots in the nation of 51 million people. |
| If you like this story, share it with a friend! | If you like this story, share it with a friend! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |